Suk Hang Cheng
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 22
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 13
- RNA modifications and cancer 7
- Renal and related cancers 5
- Single-cell and spatial transcriptomics 4
- Oncology top 5%
- Viral-associated cancers and disorders 5
-
- Prenatal Screening and Diagnostics 16
-
- Multiple Myeloma Research and Treatments 4
Suk Hang Cheng
47 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Cancer Research 2.0k
- Molecular Biology 1.9k
- Oncology 749
- Pediatrics, Perinatology and Child Health 457
- Pathology and Forensic Medicine 376
Countries citing papers authored by Suk Hang Cheng
This map shows the geographic impact of Suk Hang Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suk Hang Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suk Hang Cheng more than expected).
Fields of papers citing papers by Suk Hang Cheng
This network shows the impact of papers produced by Suk Hang Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suk Hang Cheng. The network helps show where Suk Hang Cheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Suk Hang Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 4 | |
| 4 | 2024 | 10 | |
| 5 | 2022 | 21 | |
| 6 | 2022 | 5 | |
| 7 | 2021 | 14 | |
| 8 | 2020 | 13 | |
| 9 | 2020 | 76 | |
| 10 | 2019 | 153 | |
| 11 | 2019 | 57 | |
| 12 | 2016 | 127 | |
| 13 | 2013 | 25 | |
| 14 | 2013 | 20 | |
| 15 | 2012 | 48 | |
| 16 | 2012 | 40 | |
| 17 | 2010 | 113 | |
| 18 | 2010 | 48 | |
| 19 | 2009 | 36 | |
| 20 | 2009 | 24 |
About Suk Hang Cheng
Suk Hang Cheng is a scholar working on Cancer Research, Pediatrics, Perinatology and Child Health and Hematology, having authored 49 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (22 papers), Prenatal Screening and Diagnostics (16 papers), Epigenetics and DNA Methylation (13 papers), RNA modifications and cancer (7 papers), Viral-associated cancers and disorders (5 papers), Renal and related cancers (5 papers), Single-cell and spatial transcriptomics (4 papers) and Multiple Myeloma Research and Treatments (4 papers). The work is most often cited by research in Cancer Research (2.0k citations), Molecular Biology (1.9k citations) and Oncology (749 citations). Suk Hang Cheng has collaborated with scholars based in Hong Kong, China and United States. Frequent co-authors include Peiyong Jiang, Yuk Ming Dennis Lo, Rossa W. K. Chiu, K.C. Allen Chan, John Wong, Stephen L. Chan, Tak Yeung Leung, Kun Sun, Paul B.S. Lai and Vincent Wai‐Sun Wong. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.